Clinical trial
Drug Interaction Study of YZJ-1139 Tablets With Ticagrelor Tablets
NCT06671470 is registered in ClinicalTrials.gov with Shanghai Haiyan Pharmaceutical Technology Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Drug Interaction Study of YZJ-1139 Tablets With Ticagrelor Tablets
- Lead sponsor
- Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 22, 2024
- Completion date
- October 15, 2024
- Enrollment
- 27 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
insomnia